Deregulated PAX-5 transcription from a translocated IgH promoter in marginal zone lymphoma

被引:73
作者
Morrison, AM
Jäger, U
Chott, A
Schebesta, M
Haas, OA
Busslinger, M
机构
[1] Res Inst Mol Pathol, A-1030 Vienna, Austria
[2] Univ Vienna, Sch Med, Vienna, Austria
[3] St Anna Childrens Hosp, A-1090 Vienna, Austria
关键词
D O I
10.1182/blood.V92.10.3865.422k01_3865_3878
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The PAX-5 gene codes for the transcription factor BSAP, which is expressed throughout B-cell development. Although loss-of-function mutation in the mouse showed an essential role for Pax-5 in early B lymphopoiesis, gain-of-function mutations have implicated the human PAX-5 gene in the control of late B-cell differentiation. PAX-5 (on 9p13) has been involved together with the immunoglobulin heavy-chain (IgH) gene (on 14q32) in the recurring t(9;14)(p13:q32) translocation that is characteristic of small lymphocytic lymphoma with plasmacytoid differentiation. Here we have characterized a complex t(2;9;14)(p12;p13;q32) translocation present in a closely related non-Hodgkin's lymphoma referred to as splenic marginal zone lymphoma (MZL). In this MZL-1 translocation, the two promoters of PAX-5 were replaced on the derivative chromosome 14 by an immunoglobulin switch S mu promoter that was linked to the structural PAX-C gene upstream of its translation initiation codon in exon 1B. Expression analyses confirmed that PAX-5 transcription was upregulated due to efficient initiation at the S mu promoter in the malignant B lymphocytes of patient MZL-1. For comparison we have analyzed PAX-5 expression in another B-cell lymphoma, KIS-1, indicating that transcription from the distal PAX-5 promoter was increased in this tumor in agreement with the previously characterized translocation of the immunoglobulin E mu enhancer adjacent to PAX-5 exon 1A. In both lymphomas, the J-chain gene, which is thought to be under negative control by BSAP, was not expressed, whereas transcription of the putative target gene p53 was unaffected by PAX-5 overexpression. Together these data indicate that the t(9;14)(p13;q32) translocation contributes to lymphoma formation as a regulatory mutation that leads to increased PAX-B expression in late B-cell differentiation due to promoter replacement or enhancer insertion. (C) 1998 by The American Society of Hematology.
引用
收藏
页码:3865 / 3878
页数:14
相关论文
共 55 条
[51]  
Usui T, 1997, J IMMUNOL, V158, P3197
[52]   DEVELOPMENTAL REGULATION OF MICRO-INJECTED HISTONE GENES IN SEA-URCHIN EMBRYOS [J].
VITELLI, L ;
KEMLER, I ;
LAUBER, B ;
BIRNSTIEL, ML ;
BUSSLINGER, M .
DEVELOPMENTAL BIOLOGY, 1988, 127 (01) :54-63
[53]   THE B-CELL-SPECIFIC TRANSCRIPTION FACTOR BSAP REGULATES B-CELL PROLIFERATION [J].
WAKATSUKI, Y ;
NEURATH, MF ;
MAX, EE ;
STROBER, W .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (04) :1099-1108
[54]   THE HUMAN IMMUNOGLOBULIN-KAPPA LOCUS CONSISTS OF 2 COPIES THAT ARE ORGANIZED IN OPPOSITE POLARITY [J].
WEICHHOLD, GM ;
OHNHEISER, R ;
ZACHAU, HG .
GENOMICS, 1993, 16 (02) :503-511
[55]   Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma [J].
Ye, BH ;
Chaganti, S ;
Chang, CC ;
Niu, H ;
Corradini, P ;
Chaganti, RSK ;
DallaFavera, R .
EMBO JOURNAL, 1995, 14 (24) :6209-6217